NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT
NewAmsterdam Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.14M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 1.59M | 1.88M | 1.57M | 7.96M | 1.38M | 5.62M | 46.75M | 46.75M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 19.14M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 1.59M | 1.88M | 1.57M | 7.96M | 1.38M | 5.62M | 46.75M | 46.75M | n/a | n/a | n/a | n/a |
Operating Income | -35.63M | -68.92M | -43.23M | -25M | -52.58M | -55.48M | -44.3M | -47.97M | -38.93M | -36.74M | -30.43M | -28.64M | 26.81M | 26.81M | -10.85M | -9.94M | -4.98M | -4.98M |
Interest Income | 7.05M | 7.35M | 4.49M | 4.44M | 4.87M | 3.08M | 2.52M | 2.75M | 4.23M | 869.35K | n/a | 58.88K | 87.5K | 87.5K | 189.24K | 35K | 68.5K | 68.5K |
Pretax Income | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -42.53M | -46.07M | -35.09M | -38.74M | -40.45M | -38.82M | 27.26M | 27.26M | -17.69M | -9.56M | -4.74M | -4.74M |
Net Income | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -42.54M | -46.09M | -35.09M | -38.74M | -40.45M | -38.82M | 27.26M | 27.26M | -17.69M | -9.56M | -4.74M | -4.74M |
Selling & General & Admin | 27.26M | 27.15M | 24.31M | 17.28M | 15.3M | 14.45M | 10.17M | 10.92M | 9.03M | 7.43M | 4.79M | 5.3M | 4.65M | 4.65M | 2.17M | 1.7M | 700.5K | 700.5K |
Research & Development | 27.52M | 44.75M | 34.9M | 35.7M | 38.38M | 42.43M | 35.72M | 38.92M | 31.47M | 37.26M | 27.03M | 28.96M | 15.29M | 15.29M | 8.68M | 8.24M | 4.28M | 4.28M |
Other Expenses | n/a | n/a | -3.21M | 1.14M | 1.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 54.78M | 71.9M | 56M | 54.11M | 54.85M | 56.88M | 46.64M | 50.7M | 40.89M | 47.56M | 31.81M | 44.38M | 19.41M | 19.41M | 17.5M | 9.52M | 4.67M | 4.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | 962.78K | 3.1M | 1.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -11.14M | 3.55M | 3.52M | n/a | 1.64M | 1.72M | 429.79K | n/a | 523.73K | 562.3K | 309.5K | 309.5K | 419.24K | 405.5K | 17K | 17K |
Cost & Expenses | 54.78M | 71.9M | 56M | 54.11M | 54.85M | 56.88M | 46.64M | 50.7M | 40.89M | 47.56M | 31.81M | 44.38M | 19.41M | 19.41M | 17.5M | 9.52M | 4.67M | 4.67M |
Income Tax Expense | n/a | n/a | n/a | -1K | n/a | n/a | 12.23K | 12.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
Shares Outstanding (Diluted) | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 82.48M | 81.85M | 81.63M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
EPS (Basic) | -0.15 | -0.34 | -0.98 | -0.18 | -0.38 | -0.98 | -0.52 | -0.56 | -0.43 | -0.47 | -2.2 | -23.19 | 0.75 | 0.75 | -1.73 | -0.82 | -0.43 | -0.43 |
EPS (Diluted) | -0.15 | -0.34 | -0.98 | -0.18 | -0.38 | -0.98 | -0.52 | -0.56 | -0.43 | -0.47 | -2.2 | -23.22 | 0.67 | 0.68 | -1.73 | -0.82 | -0.43 | -0.43 |
EBITDA | -35.59M | -68.87M | -111.69M | -23.84M | -51.38M | -55.47M | -44.29M | -48.27M | -38.99M | -38.62M | -30.43M | -28.63M | 26.83M | 26.83M | -10.85M | -9.94M | -4.98M | -4.98M |
EBIT | -35.63M | -68.92M | -111.74M | -23.87M | -51.4M | -55.48M | -51M | -48.28M | -39M | -38.63M | -30.43M | -28.64M | 26.81M | 26.81M | -10.85M | -9.94M | -4.98M | -4.98M |
Depreciation & Amortization | 45K | 52K | 51K | 28K | 19K | 15K | 5.17K | 6.16K | 11.91K | 8.3K | 2.25K | 7.54K | 18K | 18K | 1.4K | 1K | 1K | 1K |